(Q39388222)

11 September 2017

title

Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease (English)

1 reference

11 September 2017

0 references

0 references

Per Almqvist

18

0 references

Göran Lind

Göran Lind

Maria Kristoffersen Wiberg

3

0 references

Maria Wiberg

15

0 references

Lars-Olof Wahlund

Lars-Olof Wahlund

13

0 references

Kaj Blennow

7

Kaj Blennow

1 reference

11 September 2017

Ove Almkvist

5

0 references

Agneta Nordberg

Agneta Nordberg

11

0 references

Bengt Winblad

16

Bengt Winblad

1 reference

11 September 2017

10

Ahmadul Kadir

1 reference

11 September 2017

2

Bengt Linderoth

1 reference

11 September 2017

17

Ake Seiger

1 reference

11 September 2017

8

Nenad Bogdanovic

1 reference

Maria Eriksdotter Jönhagen

11 September 2017

1

Maria Eriksdotter-Jönhagen

1 reference

11 September 2017

Layth Aladellie

4

1 reference

11 September 2017

Niels Andreasen

6

1 reference

11 September 2017

Vesna Jelic

9

1 reference

11 September 2017

Erik Sundström

12

1 reference

11 September 2017

Anders Wall

14

1 reference

11 September 2017

Lars Wahlberg

19

1 reference

11 September 2017

publication date

22 February 2012

1 reference

Dementia and Geriatric Cognitive Disorders

11 September 2017

published in

1 reference

11 September 2017

volume

33

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

18-28

1 reference

Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients.

11 September 2017

cites work

1 reference

On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis

21 January 2018

1 reference

The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?

21 January 2018

1 reference

Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor

21 January 2018

1 reference

NGF is essential for hippocampal plasticity and learning

21 January 2018

1 reference

Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat.

21 January 2018

1 reference

Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease

21 January 2018

1 reference

Nerve growth factor in treatment and pathogenesis of Alzheimer's disease.

21 January 2018

1 reference

Cholinergic system during the progression of Alzheimer's disease: therapeutic implications

21 January 2018

1 reference

The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease

21 January 2018

1 reference

Cholinergic involvement in Alzheimer's disease. A link with NGF maturation and degradation

21 January 2018

1 reference

Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease

21 January 2018

1 reference

Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials

21 January 2018

1 reference

Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

21 January 2018

1 reference

Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease

21 January 2018

1 reference

Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice.

21 January 2018

1 reference

Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity

21 January 2018

1 reference

Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery

21 January 2018

1 reference

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

21 January 2018

1 reference

Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?

21 January 2018

1 reference

Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons

21 January 2018

1 reference

Long-term delivery of nerve growth factor by encapsulated cell biodelivery in the Göttingen minipig basal forebrain.

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

21 January 2018

1 reference

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease

21 January 2018

1 reference

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

21 January 2018

1 reference

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

21 January 2018

1 reference

A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults

21 January 2018

1 reference

Asymptomatic transient MRI signal changes after unilateral deep brain stimulation electrode implantation for movement disorder

21 January 2018

1 reference

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.

21 January 2018

1 reference

Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.

21 January 2018

1 reference

Nerve growth factor treatment in dementia

21 January 2018

1 reference

Growth-factor gene therapy for neurodegenerative disorders

21 January 2018

1 reference

Neurochemical aftermath of amateur boxing

21 January 2018

1 reference

Post-transcriptional control of neurofilaments: New roles in development, regeneration and neurodegenerative disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000336051

1 reference

11 September 2017

1 reference